质子泵抑制剂与抗血小板药.pptVIP

Balance between Benefits and Risks The potential benefits of antiplatelet therapy for atherosclerotic cardiovascular (CV) disease have been amply demonstrated over the past 20 years, especially thienopyridine drugs in preventing stent thrombosis. Antiplatelet agents increase the risk of bleeding associated with mucosal breaks in the upper and lower gastrointestinal (GI) tract. Rational use of thienopyridines is based on weighing their risks against their benefits. Potential adverse interaction Many investigations of potential adverse interaction has been conducted recently Evidence of a poss